Background
Methods
Ethical standard
Diagnostic criteria
Study population for polymorphism analysis
Blood samples and DNA preparation
SNP selection
SNP genotyping
Statistical analysis
GENE | Tag SNP | Genotype groups | Association test |
---|---|---|---|
CCR5
|
rs3176763
| CC vs CA + AA | p = 0.006; OR = 1.79; 95% CI: 1.18-2.70 |
rs3087253
| AA vs AT + TT | p = 0.640; OR = 1.06; 95% CI: 0.84-1.32 | |
rs11575815
| AA + AT vs TT | p = 0.030; OR = 1.41; 95% CI: 1.03-1.92 | |
CCL2
|
rs3760396
| GG vs GA + AA | p = 0.373; OR = 1.13; 95% CI: 0.87-1.46 |
rs2857656
| CC vs CG + GG | p = 0.440; OR = 1.09; 95% CI: 0.87-1.36 | |
rs4586
| TT vs TC + CC | p = 0.032; OR = 1.30; 95% CI: 1.02-1.65 | |
rs3917891
| CC vs CT + TT | p = 0.037; OR = 1.56; 95% CI: 1.03-2.37 | |
rs2530797
| AA vs AG + GG | p = 0.028; OR = 1.28; 95% CI: 1.03-1.60 | |
rs991804
| CC vs CT + TT | p = 0.493; OR = 1.17; 95% CI: 0.75-1.82 | |
TIRAP
|
rs11220437
| TT vs TC + CC | p = 0.155; OR = 1.21; 95% CI: 0.93-1.58 |
rs591163
| GG + GA vs AA | p = 0.237; OR = 1.01; 95% CI: 0.79-1.30 | |
rs8177352
| AA vs AG + GG | p = 0.913; OR = 2.06; 95% CI: 0.45-9.55 | |
rs8177375
| AA vs AG + GG | p = 0.203; OR = 1.21; 95% CI: 0.90-1.61 | |
rs8177376
| AA vs AC + CC | p = 0.004; OR = 1.42; 95% CI: 1.12-1.80 | |
rs17866704
| TT vs TC + CC | p = 0.023; OR = 1.31; 95% CI: 1.04-1.66 |
GENE | Tag SNP | Genotype groups | Association test |
---|---|---|---|
CCR5
|
rs3176763
| CC vs CA + AA | p = 0.005; OR = 1.88; 95% CI: 1.20-2.94 |
rs3087253
| AA vs AT + TT | p = 0.861; OR = 1.02; 95% CI: 0.80-1.31 | |
rs11575815
| AA + AT vs TT | p = 0.138; OR = 1.29; 95% CI: 0.92-1.82 | |
CCL2
|
rs3760396
| GG vs GA + AA | p = 0.920; OR = 1.02; 95% CI: 0.77-1.35 |
rs2857656
| CC vs CG + GG | p = 0.514; OR = 1.08; 95% CI: 0.85-1.39 | |
rs4586
| TT vs TC + CC | p = 0.034; OR = 1.34; 95% CI: 1.02-1.75 | |
rs3917891
| CC vs CT + TT | p = 0.053; OR = 1.55; 95% CI: 1.00-2.41 | |
rs2530797
| AA vs AG + GG | p = 0.005; OR = 1.42; 95% CI: 1.11-1.82 | |
rs991804
| CC vs CT + TT | p = 0.824; OR = 1.06; 95% CI: 0.65-1.73 | |
TIRAP
|
rs11220437
| TT vs TC + CC | p = 0.181; OR = 1.22; 95% CI: 0.91-1.63 |
rs591163
| GG + GA vs AA | p = 0.188; OR = 1.39; 95% CI: 0.88-1.90 | |
rs8177352
| AA vs AG + GG | p = 0.858; OR = 1.02; 95% CI: 0.78-1.34 | |
rs8177375
| AA vs AG + GG | p = 0.174; OR = 1.25; 95% CI: 0.91-1.69 | |
rs8177376
| AA vs AC + CC | p = 0.005; OR = 1.46; 95% CI: 1.12-1.91 | |
rs17866704
| TT vs TC + CC | p = 0.087; OR = 1.25; 95% CI: 0.97-1.62 |
CCC VS ASY | |||
---|---|---|---|
GENE | Tag SNP | Genotype groups | Association test |
CCL2
|
rs3760396
| GG vs GA + AA | p = 0.626; OR = 1.35; 95% CI: 0.40-4.55 |
rs2857656
| CC vs CG + GG | p = 0.267; OR = 1.16; 95% CI: 0.89-1.51 | |
rs4586
| TT vs TC + CC | p = 0.128; OR = 1.25; 95% CI: 1.94-1.67 | |
rs3917891
| CC vs CT + TT | p = 0.127; OR = 1.42; 95% CI: 0.90-2.23 | |
rs2530797
| AA vs AG + GG | p = 0.007; OR = 1.46; 95% CI: 1.11-1.92 | |
rs991804
| CC vs CT + TT | p = 0.435; OR = 1.23; 95% CI: 0.73-2.09 | |
TIRAP
|
rs11220437
| TT vs TC + CC | p = 0.149; OR = 1.27; 95% CI: 0.92-1.75 |
rs591163
| GG + GA vs AA | p = 0.154; OR = 1.32; 95% CI: 0.90-1.94 | |
rs8177352
| AA vs AG + GG | p = 0.278; OR = 1.20; 95% CI: 0.87-1.66 | |
rs8177375
| AA vs AG + GG | p = 0.256; OR = 1.22; 95% CI: 0.87-1.72 | |
rs8177376
| AA vs AC + CC | p = 0.037; OR = 1.36; 95% CI: 1.19-1.80 | |
rs17866704
| TT vs TC + CC | p = 0.051; OR = 1.32; 95% CI: 1.00-1.76 | |
CCC with a left ventricular ejection fraction value under 0.4% VS ASY
| |||
GENE
|
Tag SNP
|
Genotype groups
|
Association test
|
CCL2
|
rs3760396
| GG vs GA + AA | p = 0.392; OR = 1.84; 95% CI: 0.45-7.46 |
rs2857656
| CC vs CG + GG | p = 0.499; OR = 1.10; 95% CI: 0.83-1.46 | |
rs4586
| TT vs TC + CC | p = 0.194; OR = 1.23; 95% CI: 0.90-1.67 | |
rs3917891
| CC vs CT + TT | p = 0.156; OR = 1.40; 95% CI: 0.88-2.24 | |
rs2530797
| AA vs AG + GG | p = 0.002; OR = 1.59; 95% CI: 1.19-2.13 | |
rs991804
| CC vs CT + TT | p = 0.876; OR = 1.05; 95% CI: 0.60-1.83 | |
TIRAP
|
rs11220437
| TT vs TC + CC | p = 0.265; OR = 1.21; 95% CI: 0.86-1.71 |
rs591163
| GG + GA vs AA | p = 0.134; OR = 1.38; 95% CI: 0.91-2.10 | |
rs8177352
| AA vs AG + GG | p = 0.224; OR = 1.23; 95% CI: 0.88-1.73 | |
rs8177375
| AA vs AG + GG | p = 0.313; OR = 1.21; 95% CI: 0.84-1.74 | |
rs8177376
| AA vs AC + CC | p = 0.046; OR = 1.36; 95% CI: 1.05-1.85 | |
rs17866704
| TT vs TC + CC | p = 0.095; OR = 1.29; 95% CI: 0.96-1.74 |
Results and discussion
GENE | Tag SNP | Position relative to coordinate system | Position relative to transcription start point |
---|---|---|---|
CCR5
| rs3176763 C/A | 46414281 | −113 |
rs3087253 A/G | 46418689 | +4295 | |
rs11575815 A/T | 46420170 | +5776 | |
CCL2
| rs3760396 G/C | 32581441 | −928 |
rs2857656 C/G | 32582007 | −362 | |
rs4586 T/C | 32583269 | +900 | |
rs3917891 C/T | 32585687 | +3318 | |
rs2530797 A/G | 32586094 | +3725 | |
rs991804 C/T | 32587725 | +5356 | |
TIRAP
| rs11220437 T/C | 126148160 | −12630 |
rs591163 G/A | 126148432 | −12358 | |
rs8177352 A/G | 126153843 | −6947 | |
rs8177375 A/G | 126163064 | +2274 | |
rs8177376 A/C | 126163612 | +2822 | |
rs17866704 T/C | 126165757 | +4967 |
ASY | CCC | CCC (EF ≤ 0.4) | CCC (EF ≥ 0.4) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene | SNP | Genotype | Total | Male | Female | Total | Male | Female | Total | Male | Female | Total | Male | Female |
CCR5
|
rs3176763
|
CC
|
110
| 50 | 59 |
266
| 167 | 97 |
169
| 127 | 42 |
88
| 34 | 54 |
(94.0%)
| (96.2%) | (92.2%) |
(84.4%)
| (87.0%) | (80.2%) |
(84.9%)
| (88.2%) | (76.4%) |
(89.0%)
| (81.0%) | (84.4%) | |||
CA
|
7
| 2 | 5 |
48
| 25 | 23 |
30
| 17 | 13 |
17
| 8 | 9 | ||
(6.0%)
| (3.8%) | (7.8%) |
(15.2%)
| (13.0%) | (19.0%) |
(15.1%)
| (11.8%) | (23.6%) |
(16.0%)
| (19.0%) | (14.1%) | |||
AA
|
0
| 0 | 0 |
1
| 0 | 1 |
0
| 0 | 0 |
1
| 0 | 1 | ||
(0.0%)
| (0.0%) | (0.0%) |
(0.3%)
| (0.0%) | (0.8%) |
(0.0%)
| (0.0%) | (0.0%) |
(0.9%)
| (0.0%) | (1.6%) | |||
CCR5
|
rs3087253
|
AA
|
46
| 18 | 28 |
134
| 81 | 52 |
80
| 61 | 19 |
52
| 20 | 32 |
(41.4%)
| (36.7%) | (45.9%) |
(43.9%)
| (43.5%) | (44.4%) |
(41.0%)
| (43.3%) | (35.2%) |
(51.0%)
| (50.0%) | (51.6%) | |||
AG
|
47
| 22 | 24 |
119
| 73 | 46 |
80
| 52 | 28 |
34
| 16 | 18 | ||
(42.3%)
| (44.9%) | (39.3%) |
(39.0%)
| (39.2%) | (39.3%) |
(41.0%)
| (36.9%) | (51.9%) |
(33.3%)
| (40.0%) | (29.0%) | |||
GG
|
18
| 9 | 9 |
52
| 32 | 19 |
35
| 28 | 7 |
16
| 4 | 12 | ||
(16.2%)
| (18.4%) | (14.8%) |
(17.0%)
| (17.2%) | (16.2%) |
(17.9%)
| (19.9%) | (13.0%) |
(15.7%)
| (10.0%) | (19.4%) | |||
CCR5
|
rs11575815
|
AA
|
51
| 25 | 25 |
158
| 97 | 60 |
104
| 74 | 22 |
51
| 22 | 29 |
(45.1%)
| (49.0%) | (41.0%) |
(51.3%)
| (51.6%) | (50.8%) |
(52.8%)
| (52.1%) | (53.7%) |
(50.0%)
| (53.7%) | (47.5%) | |||
AT
|
42
| 20 | 22 |
120
| 70 | 49 |
71
| 50 | 16 |
43
| 16 | 27 | ||
(37.2%)
| (39.2%) | (36.1%) |
(39.0%)
| (37.2%) | (41.5%) |
(36.0%)
| (35.2%) | (39.0%) |
(42.2%)
| (39.0%) | (44.3%) | |||
TT
|
20
| 6 | 14 |
30
| 21 | 9 |
22
| 18 | 3 |
8
| 3 | 5 | ||
(17.7%)
| (11.8%) | (23.0%) |
(9.7%)
| (11.2%) | (7.6%) |
(11.2%)
| (12.7%) | (7.3%) |
(7.8%)
| (7.3%) | (8.2%) | |||
CCL2
|
rs3760396
|
GG
|
87
| 41 | 45 |
247
| 152 | 94 |
153
| 112 | 41 |
87
| 36 | 51 |
(75.7%)
| (80.4%) | (71.4%) |
(79.9%)
| (80.9%) | (79.0%) |
(77.7%)
| (78.9%) | (74.5%) |
(85.3%)
| (90.0%) | (82.3%) | |||
GC
|
27
| 9 | 18 |
60
| 35 | 24 |
43
| 29 | 14 |
14
| 4 | 10 | ||
(23.5%)
| (17.6%) | (28.6%) |
(19.4%)
| (18.6%) | (20.2%) |
(21.8%)
| (20.4%) | (25.5%) |
(13.7%)
| (10.0%) | (16.1%) | |||
CC
|
1
| 1 | 0 |
2
| 1 | 1 |
1
| 1 | 0 |
1
| 0 | 1 | ||
(0.9%)
| (2.0%) | (0.0%) |
(0.6%)
| (0.5%) | (0.8%) |
(0.5%)
| (0.7%) | (0.0%) |
(1.0%)
| (0.0%) | (1.6%) | |||
CCL2
|
rs2857656
|
CC
|
50
| 24 | 25 |
122
| 70 | 50 |
77
| 52 | 25 |
42
| 17 | 25 |
(44.2%)
| (48.0%) | (40.3%) |
(39.7%)
| (37.6%) | (42.0%) |
(39.3%)
| (36.9%) | (45.5%) |
(41.2%)
| (42.5%) | (40.3%) | |||
CG
|
51
| 22 | 29 |
150
| 92 | 58 |
96
| 72 | 24 |
51
| 18 | 33 | ||
(45.1%)
| (44.0%) | (46.8%) |
(48.9%)
| (49.5%) | (48.7%) |
(49.0%)
| (51.1%) | (43.6%) |
(50.0%)
| (45.0%) | (53.2%) | |||
GG
|
12
| 4 | 8 |
35
| 24 | 11 |
23
| 17 | 6 |
9
| 5 | 4 | ||
(10.6%)
| (8.0%) | (12.9%) |
(11.4%)
| (12.9%) | (9.2%) |
(11.7%)
| (12.1%) | (10.9%) |
(8.8%)
| (12.5%) | (6.5%) | |||
CCL2
|
rs4586
|
TT
|
38
| 20 | 18 |
74
| 41 | 32 |
46
| 31 | 15 |
26
| 9 | 17 |
(34.5%)
| (40.8%) | (30.0%) |
(24.0%)
| (21.7%) | (27.4%) |
(23.4%)
| (21.8%) | (27.3%) |
(25.5%)
| (22.0%) | (27.9%) | |||
TC
|
53
| 23 | 29 |
148
| 90 | 57 |
94
| 70 | 24 |
52
| 19 | 33 | ||
(48.2%)
| (49.9%) | (48.3%) |
(48.1%)
| (47.6%) | (48.7%) |
(47.7%)
| (49.3%) | (43.6%) |
(51.0%)
| (46.3%) | (54.1%) | |||
CC
|
19
| 6 | 13 |
86
| 58 | 28 |
57
| 41 | 16 |
26
| 13 | 11 | ||
(17.3%)
| (12.2%) | (21.7%) |
(27.9%)
| (30.7%) | (23.9%) |
(28.9%)
| (28.9%) | (29.1%) |
(25.5%)
| (31.7%) | (18.0%) | |||
CCL2
|
rs3917891
|
CC
|
107
| 47 | 59 |
264
| 161 | 101 |
166
| 120 | 46 |
91
| 37 | 54 |
(93.9%)
| (90.4%) | (96.7%) |
(86.0%)
| (86.1%) | (85.6%) |
(85.6%)
| (85.7%) | (85.2%) |
(88.3%)
| (90.2%) | (87.1%) | |||
CT
|
7
| 5 | 2 |
41
| 25 | 16 |
26
| 19 | 7 |
12
| 4 | 8 | ||
(6.1%)
| (9.6%) | (3.3%) |
(13.4%)
| (13.4%) | (13.6%) |
(13.4%)
| (13.6%) | (13.0%) |
(11.7%)
| (9.9%) | (12.9%) | |||
TT
|
0
| 0 | 0 |
2
| 1 | 1 |
2
| 1 | 1 |
0
| 0 | 0 | ||
(0.0%)
| (0.0%) | (0.0%) |
(0.7%)
| (0.5%) | (0.8%) |
(1.0%)
| (0.7%) | (1.9%) |
(0.0%)
| (0.0%) | (0.0%) | |||
CCL2
|
rs2530797
|
AA
|
47
| 13 | 33 |
163
| 104 | 58 |
110
| 81 | 29 |
47
| 19 | 28 |
(41.6%)
| (25.5%) | (54.1%) |
(52.9%)
| (55.6%) | (48.7%) |
(55.8%)
| (57.0%) | (52.7%) |
(45.6%)
| (47.5%) | (44.4%) | |||
AG
|
52
| 33 | 19 |
115
| 68 | 46 |
69
| 51 | 18 |
44
| 16 | 28 | ||
(46.0%)
| (64.7%) | (31.1%) |
(37.3%)
| (36.4%) | (38.7%) |
(35%)
| (35.9%) | (32.7%) |
(42.7%)
| (40%) | (44.4%) | |||
GG
|
14
| 5 | 9 |
30
| 15 | 15 |
18
| 10 | 8 |
12
| 5 | 7 | ||
(12.4%)
| (9.8%) | (14.8%) |
(9.7%)
| (8.0%) | (12.6%) |
(9.1%)
| (7.0%) | (14.5%) |
(11.7%)
| (12.5%) | (11.1%) | |||
CCL2
|
rs991804
|
CC
|
51
| 25 | 25 |
120
| 67 | 51 |
78
| 52 | 26 |
40
| 15 | 25 |
(45.5%)
| (48.1% | (42.4%) |
(41.2%)
| (38.3%) | (44.7%) |
(42.6%)
| (39.4%) | (51.0%) |
(40.4%)
| (39.5%) | (41.0%) | |||
CT
|
53
| 24 | 29 |
148
| 92 | 56 |
88
| 67 | 21 |
54
| 20 | 34 | ||
(47.3%)
| (46.2%) | (49.2%) |
(50.9%)
| (52.6%) | (51.1%) |
(48.1%)
| (50.8%) | (41.2%) |
(54.5%)
| (52.6%) | (55.7%) | |||
TT
|
8
| 3 | 5 |
23
| 16 | 7 |
17
| 13 | 4 |
5
| 3 | 2 | ||
(7.1%)
| (5.8%) | (8.5%) |
(7.9%)
| (9.1%) | (6.1%) |
(9.3%)
| (9.8%) | (7.8%) |
(5.1%)
| (7.9%) | (3.3%) | |||
TIRAP
|
rs11220437
|
TT
|
92
| 44 | 47 |
229
| 142 | 85 |
146
| 106 | 40 |
74
| 31 | 43 |
(80.0%)
| (84.6%) | (75.8%) |
(73.9%)
| (74.7%) | (72.0%) |
(73.7%)
| (73.6%) | (74.1%) |
(71.8%)
| (75.6%) | (69.4%) | |||
TC
|
22
| 8 | 14 |
76
| 45 | 31 |
48
| 36 | 12 |
28
| 9 | 19 | ||
(19.1%)
| (15.4%) | (22.6%) |
(24.5%)
| (23.7%) | (26.3%) |
(24.2%)
| (25.0%) | (22.2%) |
(27.2%)
| (22.0%) | (30.6%) | |||
CC
|
1
| 0 | 1 |
5
| 3 | 2 |
4
| 2 | 2 |
1
| 1 | 0 | ||
(9.0%)
| (0.0%) | (1.6%) |
(1.6%)
| (1.6%) | (1.7%) |
(2.0%)
| (1.4%) | (3.7%) |
(1.0%)
| (2.4%) | (0.0%) | |||
TIRAP
|
rs591163
|
GG
|
51
| 23 | 28 |
158
| 95 | 82 |
104
| 74 | 20 |
52
| 30 | 32 |
(46.4%)
| (46.9%) | (46.7%) |
(51.5%)
| (50.5%) | (53.0%) |
(53.1%)
| (52.1%) | (50.0%) |
(51.5%)
| (55.6%) | (52.5%) | |||
GA
|
44
| 19 | 24 |
120
| 76 | 43 |
75
| 56 | 16 |
38
| 19 | 22 | ||
(40.0%)
| (38.8%) | (40.0%) |
(39.1%)
| (40.4%) | (36.8%) |
(38.3%)
| (39.4%) | (40.0%) |
(37.6%)
| (35.2%) | (36.1%) | |||
AA
|
15
| 7 | 8 |
29
| 17 | 12 |
17
| 12 | 4 |
11
| 5 | 7 | ||
(13.6%)
| (14.3%) | (13.3%) |
(9.4%)
| (9.0%) | (10.3%) |
(8.7%)
| (8.5%) | (10.0%) |
(10.9%)
| (9.3%) | (11.5%) | |||
TIRAP
|
rs8177352
|
AA
|
83
| 38 | 44 |
225
| 132 | 91 |
140
| 98 | 42 |
80
| 31 | 49 |
(73.5%)
| (4.5%) | (72.1%) |
(73.3%)
| (70.6%) | (77.1%) |
(71.4%)
| (69.5%) | (76.4%) |
(77.7%)
| (75.6%) | (79.0%) | |||
AG
|
28
| 12 | 16 |
73
| 48 | 25 |
47
| 36 | 11 |
23
| 10 | 13 | ||
(24.8%)
| (23.5%) | (26.2%) |
(23.8%)
| (25.7%) | (21.2%) |
(24.0%)
| (25.5%) | (20.0%) |
(22.3%)
| (24.4%) | (21.0%) | |||
GG
|
2
| 60 | 1 |
9
| 7 | 2 |
9
| 7 | 2 |
0
| 0 | 0 | ||
(1.8%)
| (23.5%) | (1.6%) |
(2.9%)
| (3.7%) | (1.7%) |
(4.6%)
| (5.0%) | (3.6%) |
(0.0%)
| (0.0%) | (0.0%) | |||
TIRAP
|
rs8177375
|
AA
|
95
| 45 | 49 |
246
| 153 | 91 |
156
| 115 | 41 |
82
| 34 | 48 |
(84.1%)
| (88.2%) | (80.3%) |
(79.4%)
| (81.4%) | (75.8%) |
(79.2%)
| (81.0%) | (74.5%) |
(78.8%)
| (82.9%) | (76.2%) | |||
AG
|
16
| 5 | 11 |
60
| 33 | 27 |
39
| 26 | 13 |
20
| 6 | 14 | ||
(14.2%)
| (9.8%) | (18.0%) |
(19.4%)
| (17.6%) | (22.5%) |
(19.8%)
| (18.3%) | (23.6%) |
(19.2%)
| (14.6%) | (22.2%) | |||
GG
|
2
| 1 | 1 |
4
| 2 | 2 |
2
| 1 | 1 |
2
| 1 | 1 | ||
(1.8%)
| (2.0%) | (1.6%) |
(1.2%)
| (1.0%) | (1.7%) |
(1.0%)
| (0.7%) | (1.8%) |
(1.9%)
| (2.4%) | (1.6%) | |||
TIRAP
|
rs8177376
|
AA
|
63
| 26 | 37 |
230
| 143 | 85 |
149
| 110 | 39 |
74
| 29 | 45 |
(54.9%)
| (57.8%) | (60.7%) |
(75.4%)
| (77.7%) | (71.4%) |
(76.8%)
| (79.1%) | (70.9%) |
(71.8%)
| (72.5%) | (71.4%) | |||
AC
|
40
| 18 | 22 |
70
| 40 | 30 |
44
| 28 | 16 |
25
| 11 | 14 | ||
(37.7%)
| (40.0%) | (36.1%) |
(23.0%)
| (21.7%) | (25.2%) |
(22.7%)
| (20.1%) | (29.1%) |
(24.3%)
| (27.5%) | (22.2%) | |||
CC
|
3
| 1 | 2 |
5
| 1 | 4 |
1
| 1 | 0 |
4
| 0 | 4 | ||
(2.8%)
| (2.2%) | (3.3%) |
(1.6%)
| (0.5%) | (3.4%) |
(0.5%)
| (0.7%) | (0.0%) |
(3.9%)
| (0.0%) | (6.3%) | |||
TIRAP
|
rs17866704
|
TT
|
80
| 35 | 44 |
175
| 103 | 71 |
115
| 80 | 35 |
54
| 20 | 34 |
(70.8%)
| (70.0%) | (71.0%) |
(57.4%)
| (55.4%) | (60.7%) |
(59.0%)
| (56.7%) | (64.8%) |
(53.5%)
| (50.0%) | (55.7%) | |||
TC
|
32
| 15 | 17 |
106
| 64 | 41 |
63
| 46 | 17 |
40
| 16 | 24 | ||
(28.3%)
| (30.0%) | (27.4%) |
(34.8%)
| (34.4%) | (35.0%) |
(32.3%)
| (32.6%) | (31.5%) |
(39.6%)
| (40%) | (39.3%) | |||
CC
|
1
| 0 | 1 |
24
| 19 | 5 |
17
| 15 | 2 |
7
| 4 | 3 | ||
(0.9%)
| (0.0%) | (1.6%) |
(7.9%)
| (10.2%) | (4.3%) |
(8.7%)
| (10.6%) | (3.7%) |
(6.9%)
| (10.0%) | (4.9%) |
GENE | Tag SNP | Chi2 | p |
---|---|---|---|
CCR5
| rs3176763 C/A | 0.111257738 | 0.9458 |
rs3087253 A/G | 1.014584489 | 0.6021 | |
rs11575815 A/T | 0.111257738 | 0.9458 | |
CCL2
| rs3760396 G/C | 0.491314613 | 0.7821 |
rs2857656 C/G | 0.035595421 | 0.9823 | |
rs4586 T/C | 0.004981781 | 0.9975 | |
rs3917891 C/T | 0.114371123 | 0.9444 | |
rs2530797 A/G | 0.004293958 | 0.9978 | |
rs991804 C/T | 1.35646743 | 0.5075 | |
TIRAP
| rs11220437 T/C | 0.063307752 | 0.9688 |
rs591163 G/A | 1.190573349 | 0.5514 | |
rs8177352 A/G | 0.042221875 | 0.9791 | |
rs8177375 A/G | 1.69100575 | 0.4293 | |
rs8177376 A/C | 1.294967649 | 0.5233 | |
rs17866704 T/C | 1.314206075 | 0.5183 |
Polymorphisms rs3176763C/A and rs11575815A/T, around the CCR5 gene, are associated to an increased risk of CCC
GENE: | CCR5 | ||
---|---|---|---|
Step | Covariates | Groups | Association test |
Step1 | gender | Male vs Female | p = 0.002; OR = 2.042; 95% CI: 1.31-3.19 |
rs3176763 | CC vs CA + AA | p = 0.014; OR = 1.689; 95% CI: 1.11-2.57 | |
rs11575815 | AA + AT vs TT | p = 0.077; OR = 1.328; 95% CI: 1.03-1.82 | |
Step2 | gender | Male vs Female | p = 0.001; OR = 2.058; 95% CI: 1.32-3.21 |
rs3176763 | CC vs CA + AA | p = 0.007; OR = 1.766; 95% CI: 1.16-2.68 | |
rs11575815 | AA + AT vs TT | Excluded | |
GENE:
|
CCL2
| ||
Step
|
Covariates
|
Groups
|
Association test
|
Step1 | gender | Male vs Female | p = 0.002; OR = 2.056; 95% CI: 1.31-3.23 |
rs2530797 | AA vs AG + GG | p = 0.162; OR = 1.198; 95% CI: 1.07-1.54 | |
rs4586 | TT vs TC + CC | p = 0.348; OR = 1.138; 95% CI: 1.15-1.49 | |
rs3917891 | CC vs CT + TT | p = 0.131; OR = 1.392; 95% CI: 1.1-2.140 | |
Step2 | gender | Male vs Female | p = 0.002; OR = 2.070; 95% CI: 1.32-3.25 |
rs2530797 | AA vs AG + GG | p = 0.051; OR = 1.258; 95% CI: 1.00-1.59 | |
rs3917891 | CC vs CT + TT | p = 0.095; OR = 1.435; 95% CI: 1.06-2.19 | |
rs4586 | TT vs TC + CC | Excluded | |
Step3 | gender | Male vs Female | p = 0.001; OR = 2.091; 95% CI: 1.33-3.28 |
rs2530797 | AA vs AG + GG | p = 0.022; OR = 1.303; 95% CI: 1.04-1.64 | |
rs4586 | TT vs TC + CC | Excluded | |
rs3917891 | CC vs CT + TT | Excluded | |
GENE:
|
TIRAP
| ||
Step
|
Covariates
|
Groups
|
Association test
|
Step1 | gender | Male vs Female | p = 0.002; OR = 2.062; 95% CI: 1.30-3.27 |
rs8177376 | AA vs AC + CC | p = 0.013; OR = 1.357; 95% CI: 1.06-1.73 | |
rs17866704 | TT vs TC + CC | p = 0.039; OR = 1.298; 95% CI: 1.01-1.66 |
Polymorphisms rs4586T/C, rs3917891C/T and rs2530797A/G, around the CCL2 gene, are associated to an increased risk of CCC
Polymorphism rs8177376A/C, around the MAL/TIRAP gene, is associated to an an increased risk of CCC
The associations of the CCL2 and MAL/TIRAP genes were confirmed in a cohort from the original reports
ASY | CCC | CCC (EF ≤ 0.4) | CCC (EF ≥ 0.4) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene | SNP | Genotype | Total | Male | Female | Total | Male | Female | Total | Male | Female | Total | Male | Female |
CCL2
|
rs3760396
|
GG
|
61
| 30 | 30 |
208
| 128 | 79 |
140
| 99 | 41 |
76
| 28 | 36 |
(81.3%)
| (81.1%) | (81.1%) |
(80.0%)
| (80.9%) | (76.7%) |
(78.7%)
| (80.5%) | (74.5%) |
(86.4%)
| (93.3%) | (78.3%) | |||
GC
|
13
| 6 | 7 |
50
| 26 | 23 |
37
| 23 | 14 |
11
| 2 | 9 | ||
(17.3%)
| (16.2%) | (18.9%) |
(19.4%)
| (19.2%) | (22.3%) |
(20.8%)
| (18.7%) | (25.5%) |
(12.5%)
| (6.7%) | (19.6%) | |||
CC
|
1
| 1 | 0 |
2
| 1 | 1 |
1
| 1 | 0 |
1
| 0 | 1 | ||
(1.4%)
| (2.7%) | (0.0%) |
(0.6%)
| (0.9%) | (1.0%) |
(0.5%)
| (0.8%) | (0.0%) |
(1.1%)
| (0.0%) | (2.1%) | |||
CCL2
|
rs2857656
|
CC
|
34
| 16 | 17 |
101
| 57 | 42 |
71
| 46 | 25 |
28
| 11 | 17 |
(46.6%)
| (44,4%) | (47,2%) |
(38.7%)
| (36.8%) | (42.0%) |
(39.9%)
| (37,4%) | (45.5%) |
(36,4%)
| (36,7%) | (36,2%) | |||
CG
|
36
| 20 | 16 |
133
| 59 | 54 |
86
| 62 | 24 |
45
| 16 | 29 | ||
(49.3%)
| (55,6%) | (44,4%) |
(51%)
| (51%) | (51,9%) |
(48,3%)
| (50,4%) | (43.6%) |
(58,4%)
| (53,3%) | (61,7%) | |||
GG
|
3
| 0 | 3 |
27
| 19 | 8 |
21
| 15 | 6 |
4
| 3 | 1 | ||
(4,1%)
| (0%) | (8,3%) |
(10.3%)
| (12.3%) | (7,7%) |
(11.8%)
| (12.2%) | (10.9%) |
(5,2%)
| (10%) | (2,1%) | |||
CCL2
|
rs4586
|
TT
|
23
| 13 | 10 |
62
| 34 | 27 |
44
| 29 | 15 |
17
| 5 | 12 |
(32,4%)
| (37,1%) | (28,6%) |
(23,8%)
| (21.8%) | (26,5%) |
(24,6%)
| (23,4%) | (27.3%) |
(22,4%)
| (16,7%) | (26,1%) | |||
TC
|
39
| 20 | 18 |
130
| 78 | 51 |
84
| 60 | 24 |
44
| 17 | 27 | ||
(54,9%)
| (57,1%) | (51,4%) |
(50%)
| (50%) | (50%) |
(46,9%)
| (48,4%) | (43.6%) |
(57,9%)
| (56,7%) | (58,7%) | |||
CC
|
9
| 2 | 7 |
68
| 44 | 24 |
51
| 35 | 16 |
15
| 8 | 7 | ||
(12,7%)
| (5,7%) | (20%) |
(22.2%)
| (28,2%) | (23.5%) |
(28.5%)
| (28.2%) | (29.1%) |
(19,7%)
| (26,7%) | (15,2%) | |||
CCL2
|
rs3917891
|
CC
|
69
| 34 | 34 |
220
| 132 | 86 |
150
| 104 | 46 |
66
| 27 | 39 |
(92%)
| (89,5%) | (94,4%) |
(84.9%)
| (85,2%) | (84,3%) |
(84,7%)
| (84,6%) | (85.2%) |
(86,8%)
| (90%) | (84,8%) | |||
CT
|
6
| 4 | 2 |
37
| 22 | 15 |
25
| 18 | 7 |
10
| 3 | 7 | ||
(8%)
| (10,5%) | (5,6%) |
(14,3%)
| (14,2%) | (14,7%) |
(14,1%)
| (14.6%) | (13.0%) |
(13,2%)
| (10%) | (15,2%) | |||
TT
|
0
| 0 | 0 |
2
| 1 | 1 |
2
| 1 | 1 |
0
| 0 | 0 | ||
(0%)
| (0%) | (0.0%) |
(0.8%)
| (0.6%) | (1%) |
(1.1%)
| (0.8%) | (1.9%) |
(0.0%)
| (0.0%) | (0.0%) | |||
CCL2
|
rs2530797
|
AA
|
25
| 7 | 17 |
132
| 81 | 50 |
96
| 67 | 29 |
32
| 12 | 20 |
(33.8%)
| (18.9%) | (47.2%) |
(50.6%)
| (51.9%) | (48.5%) |
(53.6%)
| (54.0%) | (52,7%) |
(41.6%)
| (40.0%) | (42.6%) | |||
AG
|
40
| 26 | 14 |
104
| 62 | 41 |
65
| 47 | 18 |
38
| 15 | 23 | ||
(54.1%)
| (70.3%) | (38.9%) |
(39.8%)
| (39.7%) | (39.8%) |
(36.3%)
| (37.9%) | (32.7%) |
(49.4%)
| (50%) | (48.9%) | |||
GG
|
9
| 4 | 5 |
25
| 13 | 12 |
18
| 10 | 8 |
7
| 3 | 4 | ||
(12.2%)
| (10.8%) | (13.9%) |
(9.6%)
| (8.3%) | (11.7%) |
(10.1%)
| (8.1%) | (14,5%) |
(9.1%)
| (10.0%) | (8.5%) | |||
CCL2
|
rs991804
|
CC
|
35
| 16 | 18 |
99
| 55 | 42 |
71
| 45 | 26 |
26
| 10 | 16 |
(47.6%)
| (42,1%) | (50%) |
(40,9%)
| (38.7%) | (42,9%) |
(43%)
| (39.5%) | (51.0%) |
(36,1%)
| (37%) | (35,6%) | |||
CT
|
36
| 21 | 15 |
122
| 72 | 50 |
77
| 56 | 21 |
43
| 15 | 28 | ||
(48%)
| (55,3%) | (41,7%) |
(50.4%)
| (50,7%) | (51%) |
(46,7%)
| (49,1%) | (41.2%) |
(59,7%)
| (55.6%) | (62,2%) | |||
TT
|
4
| 1 | 3 |
21
| 15 | 6 |
17
| 13 | 4 |
3
| 2 | 1 | ||
(5,3%)
| (2,6%) | (8.3%) |
(8,7%)
| (10,6%) | (6.1%) |
(10.3%)
| (11,4%) | (7.8%) |
(4,2%)
| (7.4%) | (2,2%) | |||
TIRAP
|
rs11220437
|
TT
|
61
| 30 | 30 |
189
| 114 | 73 |
132
| 92 | 40 |
51
| 20 | 31 |
(81,3%)
| (79,8%) | (83,3%) |
(73.0%)
| (73,5%) | (71,6%) |
(74,2%)
| (74,2%) | (74.1%) |
(68%)
| (69%) | (67,4%) | |||
TC
|
13
| 8 | 5 |
65
| 38 | 27 |
42
| 30 | 12 |
23
| 8 | 15 | ||
(17,3%)
| (21,1%) | (13,9%) |
(25,1%)
| (24,5%) | (26.5%) |
(23,6%)
| (24,2%) | (22.2%) |
(30,7%)
| (27,6%) | (32,6%) | |||
CC
|
1
| 0 | 1 |
5
| 3 | 2 |
4
| 2 | 2 |
1
| 1 | 0 | ||
(1,3%)
| (0.0%) | (2,8%) |
(1.9%)
| (1.9%) | (2%) |
(2.2%)
| (1.6%) | (3.7%) |
(1.3%)
| (3.4%) | (0.0%) | |||
TIRAP
|
rs591163
|
GG
|
27
| 14 | 13 |
132
| 77 | 54 |
91
| 61 | 30 |
40
| 16 | 24 |
(38%)
| (40%) | (37,1%) |
(50,8%)
| (49,7%) | (52,4%) |
(51,4%)
| (49,6%) | (55,6%) |
(51.9%)
| (53,3%) | (51,1%) | |||
GA
|
33
| 15 | 17 |
103
| 63 | 39 |
70
| 51 | 19 |
29
| 11 | 18 | ||
(46,5%)
| (42,9%) | (48,6%) |
(39.6%)
| (40,6%) | (37,9%) |
(39,5%)
| (41,5%) | (35,2%) |
(37.7%)
| (36,7%) | (38,3%) | |||
AA
|
11
| 6 | 5 |
25
| 15 | 10 |
16
| 11 | 5 |
8
| 3 | 5 | ||
(15,5%)
| (17,1%) | (14,3%) |
(9.6%)
| (9.7%) | (9,7%) |
(9%)
| (8.9%) | (9,3%) |
(10.4%)
| (10%) | (10,6%) | |||
TIRAP
|
rs8177352
|
AA
|
59
| 30 | 28 |
192
| 111 | 79 |
129
| 87 | 42 |
59
| 22 | 37 |
(80,8%)
| (81,1%) | (80%) |
(74,1%)
| (71.6%) | (77.5%) |
(72,5%)
| (70,7%) | (76.4%) |
(77.6%)
| (73,3%) | (80,4%) | |||
AG
|
13
| 6 | 7 |
58
| 37 | 21 |
40
| 29 | 11 |
17
| 8 | 9 | ||
(17.8%)
| (16,2%) | (20%) |
(22,4%)
| (23,9%) | (20,6%) |
(22,5%)
| (23,6%) | (20.0%) |
(22.4%)
| (26,7%) | (19,6%) | |||
GG
|
1
| 1 | 0 |
9
| 7 | 2 |
9
| 7 | 2 |
0
| 0 | 0 | ||
(1.4%)
| (2,7%) | (0%) |
(3,5%)
| (4,5%) | (2%) |
(5,1%)
| (5.7%) | (3.6%) |
(0.0%)
| (0.0%) | (0.0%) | |||
TIRAP
|
rs8177375
|
AA
|
61
| 32 | 28 |
203
| 124 | 77 |
140
| 99 | 41 |
58
| 24 | 34 |
(83,6%)
| (86,5%) | (80%) |
(77,8%)
| (80%) | (74%) |
(78,7%)
| (80,5%) | (74.5%) |
(75,3%)
| (80%) | (72,3%) | |||
AG
|
10
| 4 | 6 |
54
| 29 | 25 |
36
| 23 | 13 |
17
| 5 | 12 | ||
(13,7%)
| (10,8%) | (17,1%) |
(20,7%)
| (18,7%) | (24%) |
(20,2%)
| (18.7%) | (23.6%) |
(22,1%)
| (16,7%) | (25,5%) | |||
GG
|
2
| 1 | 1 |
4
| 2 | 2 |
2
| 1 | 1 |
2
| 1 | 1 | ||
(2,7%)
| (2,7%) | (2,9%) |
(1.5%)
| (1.3%) | (1.9%) |
(1.1%)
| (0.8%) | (1.8%) |
(2,6%)
| (3,3%) | (2,1%) | |||
TIRAP
|
rs8177376
|
AA
|
42
| 19 | 23 |
195
| 121 | 72 |
134
| 95 | 39 |
56
| 24 | 32 |
(61,8%)
| (59,4%) | (63,9%) |
(75,6%)
| (78,6%) | (70,6%) |
(75,7%)
| (77,9%) | (70.9%) |
(73,3%)
| (80%) | (69,6%) | |||
AC
|
25
| 13 | 12 |
60
| 32 | 28 |
42
| 26 | 16 |
18
| 6 | 12 | ||
(36,8%)
| (40.6%) | (33,3%) |
(23.3%)
| (20,8%) | (27,5%) |
(23,7%)
| (21,3%) | (29.1%) |
(23,7%)
| (20%) | (26,1%) | |||
CC
|
1
| 0 | 1 |
3
| 1 | 2 |
1
| 1 | 0 |
2
| 0 | 2 | ||
(1,5%)
| (0%) | (2,8%) |
(1.2%)
| (0.6%) | (2%) |
(0.6%)
| (0.8%) | (0.0%) |
(2,6%)
| (0.0%) | (4.3%) | |||
TIRAP
|
rs17866704
|
TT
|
54
| 27 | 26 |
150
| 85 | 71 |
105
| 70 | 35 |
41
| 14 | 27 |
(72%)
| (75%) | (68,4%) |
(58,4%)
| (55,2%) | (60.7%) |
(59,7%)
| (57,4%) | (64.8%) |
(54,7%)
| (46,7%) | (60%) | |||
TC
|
20
| 9 | 11 |
88
| 55 | 41 |
59
| 42 | 17 |
27
| 12 | 15 | ||
(26,7%)
| (25%) | (28,9%) |
(34,2%)
| (35,7%) | (35.0%) |
(33,5%)
| (34,4%) | (31.5%) |
(36%)
| (40%) | (33,3%) | |||
CC
|
1
| 0 | 1 |
19
| 14 | 5 |
12
| 10 | 2 |
7
| 4 | 3 | ||
(1,3%)
| (0.0%) | (2.6%) |
(7,4%)
| (9,1%) | (4.3%) |
(6,8%)
| (8,2%) | (3.7%) |
(9,3%)
| (13,3%) | (6,7%) |
Step | Covariates | Groups | Association test |
---|---|---|---|
Step1
| Gender | Male vs Female | p = 0.001; OR = 2.179; 95% CI: 1.36-3.49 |
CCR5rs3176763 | CC vs CA + AA | p = 0.014; OR = 1.763; 95% CI: 1.12-2.77 | |
TIRAP rs8177376 | AA vs AC + CC | p = 0.014; OR = 1.363; 95% CI: 1.07-1.74 | |
TIRAP rs17866704 | TT vs TC + CC | p = 0.048; OR = 1.291; 95% CI: 1.01-1.66 | |
CCL2rs2530797 | AA vs AG + GG | p = 0.114; OR = 1.212; 95% CI: 1.04-1.54 | |
TIRAP rs8177376 | AA vs AC + CC | p = 0.014; OR = 1.363; 95% CI: 1.07-1.74 | |
Step2
| Gender | Male vs Female | p = 0.001; OR = 2.179; 95% CI: 1.36-3.48 |
CCR5rs3176763 | CC vs CA + AA | p = 0.008; OR = 1.842; 95% CI: 1.17-2.88 | |
TIRAP rs8177376 | AA vs AC + CC | p = 0.015; OR = 1.356; 95% CI: 1.06-1.73 | |
TIRAP rs17866704 | TT vs TC + CC | p = 0.064; OR = 1.267; 95% CI: 1.01-1.63 | |
CCL2rs2530797 | AA vs AG + GG | Excluded | |
Step3
| Gender | Male vs Female | p = 0.001; OR = 2.226; 95% CI: 1.39-3.55 |
CCR5rs3176763 | CC vs CA + AA | p = 0.007; OR = 1.879; 95% CI: 1.19-1.89 | |
TIRAP rs8177376 | AA vs AC + CC | p = 0.007; OR = 1.393; 95% CI: 1.09-1.77 | |
TIRAP rs17866704 | TT vs TC + CC | Excluded | |
CCL2rs2530797 | AA vs AG + GG | Excluded |